Market News
Recent Developments
New product launches
- In February 2022, Edwards Lifesciences, a patient-focused medical innovations for structural heart disease received U.S. Food and Drug Administration (FDA) approval for its PASCAL Transcatheter Valve Repair System to treat patients with mitral regurgitation. This minimally invasive system optimizes valve repair.
- In May 2021, Boston Scientific, innovator of less invasive medical solutions, launched the Sentinel Cerebral Protection System in Europe to prevent stroke during TAVR. This new device captures debris before it reaches the brain.
- In August 2019, BIOTRONIK, multi-national cardiovascular biomedical research and Technology Company received U.S. Food and Drug Administration (FDA) approval for PK Papyrus Covered Coronary Stent System, a first-of-its-kind covered stent specifically designed for coronary perforations. This new covered stent improves patient outcomes.
Acquisition and partnerships
- In September 2022, Zimmer Biomet, a medical technology partnered with Surgical Planning Associates to integrate personalized 3D printing technology for joint replacement surgeries. This integration aims to improve patient outcomes.
- In September 2021, Boston Scientific, innovative medical device solutions acquired Devoro Medical, developer of the Wolf thrombectomy platform, to expand its electrophysiology and structural heart product portfolio with the WOLF thrombectomy platform.
- In January 2022, Smith & Nephew, medical technology company acquired Engage Surgical, owner of the only cementless unicompartmental (partial) knee system commercially available in the U.S. to expand digital surgery capabilities by integrating Engage’s visualization technology in arthroscopic joint repair procedures.